Antimicrobial resistance (AMR) is the result of microorganisms such as bacteria, viruses, parasites, and fungi becoming resistant to antimicrobials like antibiotics, designed to kill or inhibit their growth₁. AMR is recognized around the world as a significant threat to global health and economic development, and a major driver of death potentially accounting for more deaths than HIV/AIDS and malaria worldwide₂.

By 2050, it is estimated that AMR will be responsible for up to 10 million deaths annually₃, will cause more deaths than cancer unless concerted efforts are undertaken to counter its progression, and result in $1 trillion in additional healthcare costs₃.

As the progression of AMR can render antibiotics less effective, common infections, such as wound infections, urinary tract infections, c-sections and pneumonia will increasingly be associated with severe complications and increased risk of death.